160 related articles for article (PubMed ID: 21528811)
21. Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use.
Puar A; Donegan D; Helft P; Kuhar M; Webster J; Rao M; Econs M
AACE Clin Case Rep; 2022; 8(5):217-220. PubMed ID: 36189136
[TBL] [Abstract][Full Text] [Related]
22. Tumoral calcinosis: case report.
Ansaloni L; Falaschi F; Pazè E
East Afr Med J; 2001 Mar; 78(3):165-6. PubMed ID: 12002060
[TBL] [Abstract][Full Text] [Related]
23. [Hyperphosphatemic pseudotumoral calcinosis due to FGF23 mutation with secondary amyloidosis].
Sottini L; Veniero P; De Gaetano A; Olivi L; Brunori G
G Ital Nefrol; 2022 Aug; 39(4):. PubMed ID: 36073335
[TBL] [Abstract][Full Text] [Related]
24. Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action.
Lufkin EG; Kumar R; Heath H
J Clin Endocrinol Metab; 1983 Jun; 56(6):1319-22. PubMed ID: 6687726
[TBL] [Abstract][Full Text] [Related]
25. Massive, painful tumoral calcinosis in a long-term hemodialysis patient.
Carvalho M; de Menezes IA; Riella MC
Hemodial Int; 2011 Oct; 15(4):577-80. PubMed ID: 22093521
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of new bone-like tissue formation in uremic tumoral calcinosis.
Hiramatsu R; Ubara Y; Hayami N; Yamanouchi M; Hasegawa E; Sumida K; Suwabe T; Hoshino J; Sawa N; Amizuka N; Takaichi K
Bone; 2013 Feb; 52(2):684-8. PubMed ID: 23142362
[TBL] [Abstract][Full Text] [Related]
27. Hyperphosphatemic Tumoral Calcinosis after Total Knee Arthroplasty.
Mochizuki T; Ikari K
Case Rep Orthop; 2017; 2017():1528201. PubMed ID: 29123932
[TBL] [Abstract][Full Text] [Related]
28. Uremic tumoral calcinosis: preliminary observations suggesting an association with aberrant vitamin D homeostasis.
Quarles LD; Murphy G; Econs MJ; Martinez S; Lobaugh B; Lyles KW
Am J Kidney Dis; 1991 Dec; 18(6):706-10. PubMed ID: 1962658
[TBL] [Abstract][Full Text] [Related]
29. [Tumoral calcinosis].
Douira L; Ismaili N; Raiss M; Bensaleh H; Senouci K; Hassam B; Mansouri F
Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):464-7. PubMed ID: 17507846
[TBL] [Abstract][Full Text] [Related]
30. Calcareous lesions of the distal extremities resembling tumoral calcinosis (tumoral calcinosislike lesions): clinicopathologic study of 43 cases emphasizing a pathogenesis-based approach to classification.
Laskin WB; Miettinen M; Fetsch JF
Am J Surg Pathol; 2007 Jan; 31(1):15-25. PubMed ID: 17197915
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases.
Goossens J; Courbebaisse M; Caudron E; Bahans C; Vacquerie V; Melchior J; Salle PV; Moesch C; Daudon M; Frocht V; Richette P; Ea HK; Guigonis V
Semin Arthritis Rheum; 2017 Dec; 47(3):451-455. PubMed ID: 28779847
[TBL] [Abstract][Full Text] [Related]
32. Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.
Lufkin EG; Wilson DM; Smith LH; Bill NJ; DeLuca HF; Dousa TP; Knox FG
J Clin Endocrinol Metab; 1980 Apr; 50(4):648-53. PubMed ID: 7364922
[TBL] [Abstract][Full Text] [Related]
33. Hyperphosphatemic tumoral calcinosis.
Savaci N; Avunduk MC; Tosun Z; Hoşnuter M
Plast Reconstr Surg; 2000 Jan; 105(1):162-5. PubMed ID: 10626985
[TBL] [Abstract][Full Text] [Related]
34. [Tumoral calcinosis with superinfection and sepsis].
Oeggerli P; Maurer R; Kistler H
Schweiz Med Wochenschr; 1991 Sep; 121(38):1387-92. PubMed ID: 1925469
[TBL] [Abstract][Full Text] [Related]
35. Tumoral calcinosis without hyperparathyroidism in a patient on continuous ambulatory peritoneal dialysis.
Gupta A; Sun Y; Konstantinov KN; Servilla KS; Hartshorne MF; Tzamaloukas AH
Adv Perit Dial; 2008; 24():132-6. PubMed ID: 18986017
[TBL] [Abstract][Full Text] [Related]
36. Morbus Teutschländer - a massive soft-tissue calcification of the foot in a patient on long-term hemodialysis.
Baums MH; Klinger HM; Otte S
Arch Orthop Trauma Surg; 2003 Feb; 123(1):51-3. PubMed ID: 12582798
[TBL] [Abstract][Full Text] [Related]
37. Tumoral calcinosis demonstrated on Tc-99m sestamibi scintigraphy.
Chang CY; Cheng CY; Shen DH; Bai CY; Lin LF; Huang WS
Clin Nucl Med; 2008 Dec; 33(12):920-1. PubMed ID: 19033810
[TBL] [Abstract][Full Text] [Related]
38. Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis.
Albaramki J; Dmour H; Shboul M; Bonnard C; Venkatesh B; Odeh R
Turk J Pediatr; 2019; 61(1):130-133. PubMed ID: 31559735
[TBL] [Abstract][Full Text] [Related]
39. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.
Araya K; Fukumoto S; Backenroth R; Takeuchi Y; Nakayama K; Ito N; Yoshii N; Yamazaki Y; Yamashita T; Silver J; Igarashi T; Fujita T
J Clin Endocrinol Metab; 2005 Oct; 90(10):5523-7. PubMed ID: 16030159
[TBL] [Abstract][Full Text] [Related]
40. Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features.
Favia G; Lacaita MG; Limongelli L; Tempesta A; Laforgia N; Cazzolla AP; Maiorano E
Am J Case Rep; 2014 Dec; 15():569-75. PubMed ID: 25537063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
